Skip to main content

Table 1 Baseline characteristics and laboratory parameters of all patients

From: Establishment of MELD-lactate clearance scoring system in predicting death risk of critically ill cirrhotic patients

Variables

Total (n = 881)

ICU-survival group (n = 628)

ICU-death group (n = 253)

Statistics

P

Age, years, Mean ± SD

58.65 ± 11.57

58.33 ± 11.20

59.47 ± 12.43

t =  − 1.260

0.207

Gender, n (%)

   

χ2 = 1.734

0.188

Female

288 (32.69)

197 (31.37)

91 (35.97)

  

Male

593 (67.31)

431 (68.63)

162 (64.03)

  

Insurance, n (%)

   

χ2 = 0.725

0.696

Medicare

378 (42.91)

271 (43.15)

107 (42.29)

  

Others

203 (23.04)

140 (22.29)

63 (24.90)

  

Private

300 (34.05)

217 (34.55)

83 (32.81)

  

ICU type, n (%)

   

χ2 = 11.233

0.004

MICU

486 (55.16)

327 (52.07)

159 (62.85)

  

CCU/CSRU

95 (10.78)

66 (10.51)

29 (11.46)

  

SICU/TSICU

300 (34.05)

235 (37.42)

65 (25.69)

  

Marital, n (%)

   

χ2 = 0.955

0.812

Married

389 (44.15)

272 (43.31)

117 (46.25)

  

Single

316 (35.87)

226 (35.99)

90 (35.57)

  

Widowed

52 (5.90)

38 (6.05)

14 (5.53)

  

Divorced/separated

124 (14.07)

92 (14.65)

32 (12.65)

  

Race, n (%)

   

χ2 = 5.776

0.217

White

688 (78.09)

490 (78.03)

198 (78.26)

  

Black

76 (8.63)

49 (7.80)

27 (10.67)

  

Asian

26 (2.95)

17 (2.71)

9 (3.56)

  

Hispanic

48 (5.45)

40 (6.37)

8 (3.16)

  

Others

43 (4.88)

32 (5.10)

11 (4.35)

  

ACLF, n (%)

   

χ2 = 62.746

 < 0.001

No

325 (36.89)

283 (45.06)

42 (16.60)

  

Yes

556 (63.11)

345 (54.94)

211 (83.40)

  

Pathogenesis, n (%)

   

χ2 = 2.252

0.324

Alcoholic

426 (48.35)

298 (47.45)

128 (50.59)

  

No alcoholic

438 (49.72)

320 (50.96)

118 (46.64)

  

Biliary

17 (1.93)

10 (1.59)

7 (2.77)

  

Hepatic encephalopathy, n (%)

224 (25.43)

159 (25.32)

65 (25.69)

χ2 = 0.013

0.908

Ascites, n (%)

281 (31.90)

200 (31.85)

81 (32.02)

χ2 = 0.002

0.961

Hepatocerebral syndrome, n (%)

153 (17.37)

100 (15.92)

53 (20.95)

χ2 = 3.173

0.075

RRT, n (%)

81 (9.19)

46 (7.32)

35 (13.83)

χ2 = 9.152

0.002

Vasopressors, n (%)

290 (32.92)

124 (19.75)

166 (65.61)

χ2 = 171.822

 < 0.001

Ventilation, n (%)

369 (41.88)

261 (41.56)

108 (42.69)

χ2 = 0.094

0.759

Transplantation, n (%)

106 (12.03)

104 (16.56)

2 (0.79)

χ2 = 42.375

 < 0.001

Temperature, ℃, Mean ± SD

36.66 ± 0.86

36.70 ± 0.84

36.54 ± 0.89

t = 2.590

0.010

Heart rate, times/min, Mean ± SD

94.90 ± 18.76

93.51 ± 18.51

98.34 ± 18.97

t =  − 3.480

 < 0.001

SBP, Mean ± SD

119.88 ± 20.35

121.07 ± 20.52

116.91 ± 19.66

t = 2.760

0.006

DBP, M (Q1, Q3)

63.00 (53.00, 72.00)

63.00 (54.50, 72.00)

61.00 (50.00, 71.00)

Z =  − 2.346

0.019

MAP, Mean ± SD

77.37 ± 17.96

78.39 ± 17.32

74.83 ± 19.28

t = 2.550

0.011

SPO2/FiO2, M (Q1, Q3)

100.00 (98.00, 194.00)

100.00 (99.00, 198.00)

100.00 (96.00, 178.00)

Z =  − 3.917

 < 0.001

PaO2/FiO2, M (Q1, Q3)

278.00 (170.00, 395.00)

310.00 (183.33, 418.00)

220.00 (136.67, 322.00)

Z =  − 6.493

 < 0.001

Bilirubin, mg/dL, M (Q1, Q3)

2.50 (1.20, 6.20)

2.10 (1.00, 5.00)

4.00 (1.80, 10.30)

Z = 6.223

 < 0.001

Creatinine, mg/dL, M (Q1, Q3)

1.20 (0.90, 2.20)

1.10 (0.80, 1.90)

1.60 (1.00, 2.80)

Z = 5.606

 < 0.001

INR, M (Q1, Q3)

1.70 (1.40, 2.20)

1.60 (1.30, 2.00)

2.10 (1.70, 2.60)

Z = 10.699

 < 0.001

PT, M (Q1, Q3)

17.60 (14.90, 21.40)

16.80 (14.60, 20.10)

19.70 (16.30, 24.20)

Z = 6.917

 < 0.001

Albumin, Mean ± SD

2.86 ± 0.66

2.93 ± 0.66

2.67 ± 0.61

t = 5.540

 < 0.001

Glucose, M (Q1, Q3)

118.00 (97.00, 155.00)

120.00 (99.00, 158.50)

116.00 (92.00, 146.00)

Z =  − 1.858

0.063

PH, Mean ± SD

7.36 ± 0.11

7.37 ± 0.10

7.33 ± 0.14

t = 4.790

 < 0.001

Sodium, mmol/L, Mean ± SD

135.62 ± 6.78

136.04 ± 6.31

134.58 ± 7.75

t = 2.670

0.008

Potassium, mmol/L, Mean ± SD

4.39 ± 0.97

4.36 ± 0.94

4.47 ± 1.03

t =  − 1.510

0.131

Hemoglobin, g/dL, Mean ± SD

10.84 ± 2.39

10.93 ± 2.41

10.64 ± 2.32

t = 1.650

0.099

WBC, 109/L, M (Q1, Q3)

8.90 (5.70, 13.60)

8.40 (5.40, 12.55)

10.30 (6.30, 14.90)

Z = 3.168

0.002

Chloride, Mean ± SD

102.17 ± 7.74

102.68 ± 7.31

100.92 ± 8.60

t = 2.850

0.005

PLT, 109/L, M (Q1, Q3)

114.00 (72.00, 176.00)

121.00 (76.00, 179.00)

105.00 (66.00, 170.00)

Z =  − 2.628

0.009

Lactate last, mmol/L, M (Q1, Q3)

1.90 (1.40, 3.00)

1.70 (1.30, 2.30)

3.20 (1.90, 6.40)

Z = 12.117

 < 0.001

Lactate first, mmol/L, M (Q1, Q3)

2.40 (1.60, 4.00)

2.10 (1.40, 3.40)

3.30 (2.20, 5.90)

Z = 8.680

 < 0.001

ΔLA, %, M (Q1, Q3)

16.00 (− 22.00, 45.00)

18.00 (− 14.00, 48.00)

2.00 (− 53.00, 39.00)

Z =  − 4.095

 < 0.001

ICU stay time, days, M (Q1, Q3)

3.82 (2.01, 8.58)

3.60 (2.01, 7.44)

4.72 (2.00, 11.49)

Z = 2.402

0.016

SOFA

9.00 (7.00,12.00)

8.00 (6.00,10.00)

12.00 (9.00,15.00)

Z = 11.758

 < 0.001

CLIF-SOFA

8.00 (6.00,11.00)

7.00 (5.00,10.00)

11.00 (8.00,13.00)

Z = 11.402

 < 0.001

MELD

18.72 (11.32,27.23)

16.34 (10.10,24.74)

24.89 (17.01,31.89)

Z = 8.445

 < 0.001

Child–Pugh

9.17 ± 2.44

8.84 ± 2.49

9.98 ± 2.10

t =  − 6.94

 < 0.001

CLIF-C ACLF

48.80 ± 8.80

47.29 ± 7.98

51.28 ± 9.52

T =  − 5.10

 < 0.001

CLIF-C AD

36.66 ± 1.25

31.54 ± 1.18

32.43 ± 1.48

T =  − 3.71

 < 0.001

MELD-Na

25.08 (16.04,33.81)

22.03 (14.31,31.29)

32.64 (24.04,38.65)

Z = 9.804

 < 0.001

  1. ICU, intensive care unit; MICU, medical intensive care unit; CCU, coronary care unit; CSRU, cardiac surgery care unit; ICU, surgical intensive care unit; TSICU, traumatic surgical intensive care unit; ACLF, acute chronic liver failure; RRT, renal replacement therapy; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; PaO2, arterial oxygen partial pressure; FiO2, fraction of inspired oxygen; SPO2, pulse oxygen saturation; INR, international normalized ratio; PT, prothrombin time; PLT, platelet count; WBC, white blood cell count; ΔLA, lactate clearance; SOFA, sequential organ failure assessment; CLIF-SOFA, chronic liver failure-sequential organ failure assessment; MELD, model for end-stage liver disease; CLIF-C ACLF, chronic liver failure consortium acute-on-chronic liver failure score; CLIF-C AD, chronic liver failure consortium-acute decompensation